XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Co-Development Agreement with SFJ Pharmaceuticals and Development Derivative Liability - Narrative (Details)
$ in Millions
Feb. 12, 2021
USD ($)
Cost of Borrowing  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Counterparty cost of borrowing 0.122
SFJ  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Committed funding $ 150.0
Success-based annual payments, first indication $ 450.0
Installment period, first indication 5 years
Success-based payments, first payment $ 30.0
Success-based annual payments, second indication $ 150.0
Installment period, second indication 7 years
One time payment $ 37.5
SFJ | Cost of Borrowing  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Counterparty cost of borrowing 0.010